Telescope Innovations (TELI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
11 Jun, 2026Executive summary
Achieved 57% year-over-year revenue growth, reaching $4.4M for FY 2024.
Strategic reinvestment in R&D and commercialization drove major milestones, including collaborations and new product launches.
Advanced projects in intelligent automation, lithium refinement, and battery recycling.
Financial highlights
Revenue increased to $4.4M from $2.8M in FY 2023, a 57% rise.
Expenses rose to $5.8M from $3.5M year-over-year.
Adjusted EBITDA loss improved to $152K from a $225K loss in FY 2023.
Outlook and guidance
Focus on sustainable growth and long-term industry leadership through innovation and strategic partnerships.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Telescope Innovations
- Automation-driven R&D platforms and global partnerships fuel rapid growth and innovation.TELI
Corporate presentation19 Jun 2026 - Self-driving labs and physical AI drive rapid growth and global adoption in pharma and clean tech.TELI
Planet MicroCap Las Vegas 202618 Jun 2026 - Revenues surged 80% year-over-year, fueled by SDL growth and new major contracts.TELI
Q3 202616 Jun 2026 - Year-to-date revenues exceeded last year's total, fueled by strong product sales and engagement.TELI
Q3 202411 Jun 2026 - Q1 revenue hit $1.2M, with strategic investments driving growth and innovation.TELI
Q1 202511 Jun 2026 - Revenue up 46% year-over-year, with strategic growth in AI labs and battery tech.TELI
Q2 202511 Jun 2026 - Revenue rose to $1.4M in Q3 FY2025, with strong DirectInject-LC sales and new tech milestones.TELI
Q3 202511 Jun 2026 - Revenue up 32% to $5.8M, driven by record sales and global expansion initiatives.TELI
Q4 202511 Jun 2026 - Q1 FY2026 revenue surged 125% year-over-year, with strong growth in product and research services.TELI
Q1 202611 Jun 2026